Company / Assets per Share
Charles River Laboratories Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$144.98
FY2025
5-year range
$141.14 / $160.86
FY2021-FY2025
Trend
-1.1%
vs FY2024
Sector context
#25 of 159
Health Care
What the data says
Charles River Laboratories's assets per share of $144.98 is higher than 84% of companies in the Health Care sector (FY2025). Declined from $160.86 to $144.98 over the past 2 years.
Based on SEC 10-K filings.
144.98 in FY2025 with a 5-year CAGR of +5.3%. Top quartile in the Health Care sector.
Declined from $160.86 to $144.98 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -1.3%
- 5-Year CAGR
- +5.3%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 159This company $144.98 Sector average $117.35
▼
+23.5% above sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 1.1% year-over-year.
- Ranks #25 out of 159 companies in the Health Care sector.
- Peak assets per share was recorded in FY2023.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $144.98 | -1.1% |
| FY2024 | $146.64 | -8.8% |
| FY2023 | $160.86 | +6.8% |
| FY2022 | $150.61 | +6.7% |
| FY2021 | $141.14 | +25.8% |
| FY2020 | $112.20 | +15.3% |
| FY2019 | $97.34 | +19.7% |
| FY2018 | $81.34 | +31.5% |
| FY2017 | $61.86 | +6.5% |
| FY2016 | $58.07 | +32.9% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026